Optiver Holding B.V. Taysha Gene Therapies, Inc. Transaction History
Optiver Holding B.V.
- $2.48 Billion
- Q1 2025
A detailed history of Optiver Holding B.V. transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, Optiver Holding B.V. holds 805 shares of TSHA stock, worth $2,342. This represents 0.0% of its overall portfolio holdings.
Number of Shares
805
Previous 1,353
40.5%
Holding current value
$2,342
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding TSHA
# of Institutions
133Shares Held
165MCall Options Held
70KPut Options Held
4.7K-
Avoro Capital Advisors LLC New York, NY20MShares$58.2 Million0.45% of portfolio
-
Rtw Investments, LP New York, NY18.8MShares$54.7 Million0.43% of portfolio
-
Morgan Stanley New York, NY16.8MShares$49 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$34.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$31.7 Million0.0% of portfolio
About Taysha Gene Therapies, Inc.
- Ticker TSHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,359,500
- Market Cap $141M
- Description
- Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...